Network aims to reverse the decline in Australian cardiovascular trials

The launch of an Australian and New Zealand Alliance for Cardiovascular Trials (ANZACT) aims to restore Australia’s standing in cardiovascular disease research. Professor Christopher Reid, chair of the CSANZ Clinical Trials Committee told the limbic the initiative was driven by a gradual decline in the ability of Australia to collectively participate in trials, both local ...

Already a member?

Login to keep reading.

© 2021 the limbic